Protocol EFG 10002 A Double Blind, Placebo Controlled Parallel Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Oral GW572016 Doses in Healthy Subjects

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/015/31/02

Funding

  • Glaxo Wellcome: $700,125.00